Available IPD datapackage for study 'A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis'
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00007578.0
下载链接
链接失效反馈官方服务：
资源简介：
The main purpose of this study is to evaluate the safety and efficacy of the study drug known
as ixekizumab in biologic disease modifying antirheumatic drug (bDMARD) naïve participants
with nonradiographic axial spondyloarthritis (nonrad-axSpA).
提供机构：
Vivli
创建时间：
2022-12-07
